Pembrolizumab in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder-sparing Treatment for Muscle-invasive Urothelial Cancer of the Bladder: A Multicenter Phase 2 Trial

European Urology 2026

View at publisher
Authors: Minas Platon Economides, Peter H. O’Donnell, Ajjai Shivaram Alva, Matthew I. Milowsky, Marisa Kollmeier, Scot Anthony Niglio, Jesse Benjamin Persily, Randy F. Sweis, Tracy Rose, Gopa Iyer, Daniel Spratt, Phillip Lee Palmbos
+13 more Tsivia Hochman, J. Goldberg, Kaitlyn Francese, Sarah Griglun, Dayna Leis, Gary D. Steinberg, James Steven Wysock, Peter B. Schiff, Nicholas J Sanfilippo, Samir S. Taneja, David R. Wise, William C. W. Huang, Arjun Vasant Balar
DOI: 10.1016/j.eururo.2026.02.016
Cited by: 1
References: 12

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Urinary and Genital Oncology Studies Tissue Engineering and Regenerative Medicine

Publication details

Journal / source
European Urology
Publisher
Elsevier BV
Publication date
1 April 2026
Language
EN